Dupont Capital Management Corp Homology Medicines, Inc. Transaction History

Dupont Capital Management Corp

  • $1.19 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 31, 2022
SELL
$3.64 - $7.78 $170,206 - $363,792
-46,760 Closed
0 $0
Q3 2021

Nov 03, 2021
SELL
$6.01 - $8.71 $39,726 - $57,573
-6,610 Reduced 12.39%
46,760 $368,000
Q2 2021

Jul 30, 2021
BUY
$6.02 - $9.64 $321,287 - $514,486
53,370 New
53,370 $388,000

Others Institutions Holding FIXX

# of Institutions
5
Shares Held
66.2K
Call Options Held
0
Put Options Held
0
View Full List

About Homology Medicines, Inc.

FIXX Quotes by TradingView
  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email